These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 17938883)
1. Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ. Krüger S; Papassotiriou J; Marre R; Richter K; Schumann C; von Baum H; Morgenthaler NG; Suttorp N; Welte T; Intensive Care Med; 2007 Dec; 33(12):2069-78. PubMed ID: 17938883 [TBL] [Abstract][Full Text] [Related]
2. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ. Krüger S; Ewig S; Kunde J; Hartmann O; Suttorp N; Welte T; Thorax; 2010 Mar; 65(3):208-14. PubMed ID: 20335288 [TBL] [Abstract][Full Text] [Related]
3. Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia. Masiá M; Papassotiriou J; Morgenthaler NG; Hernández I; Shum C; Gutiérrez F Clin Chem; 2007 Dec; 53(12):2193-201. PubMed ID: 17951293 [TBL] [Abstract][Full Text] [Related]
4. Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in patients with community-acquired pneumonia: results from the german competence network CAPNETZ. Krüger S; Ewig S; Giersdorf S; Hartmann O; Frechen D; Rohde G; Suttorp N; Welte T; Respir Med; 2014 Nov; 108(11):1696-705. PubMed ID: 25306251 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ. Krüger S; Ewig S; Giersdorf S; Hartmann O; Suttorp N; Welte T; Am J Respir Crit Care Med; 2010 Dec; 182(11):1426-34. PubMed ID: 20639437 [TBL] [Abstract][Full Text] [Related]
6. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections. Müller B; Süess E; Schuetz P; Müller C; Bingisser R; Bergmann A; Stolz D; Tamm M; Morgenthaler NG; Christ-Crain M J Intern Med; 2006 Dec; 260(6):568-76. PubMed ID: 17116008 [TBL] [Abstract][Full Text] [Related]
7. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Krüger S; Ewig S; Marre R; Papassotiriou J; Richter K; von Baum H; Suttorp N; Welte T; Eur Respir J; 2008 Feb; 31(2):349-55. PubMed ID: 17959641 [TBL] [Abstract][Full Text] [Related]
8. Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia. Claessens YE; Mathevon T; Kierzek G; Grabar S; Jegou D; Batard E; Loyer C; Davido A; Hausfater P; Robert H; Lavagna-Perez L; Bernot B; Plaisance P; Leroy C; Renaud B Intensive Care Med; 2010 May; 36(5):799-809. PubMed ID: 20232049 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ. Krüger S; Ewig S; Papassotiriou J; Kunde J; Marre R; von Baum H; Suttor N; Welte T; Respir Res; 2009 Jul; 10(1):65. PubMed ID: 19594893 [TBL] [Abstract][Full Text] [Related]
10. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia. Nowak A; Breidthardt T; Christ-Crain M; Bingisser R; Meune C; Tanglay Y; Heinisch C; Reiter M; Drexler B; Arenja N; Twerenbold R; Stolz D; Tamm M; Müller B; Müller C Chest; 2012 Apr; 141(4):974-982. PubMed ID: 22135381 [TBL] [Abstract][Full Text] [Related]
11. [Biomarkers in community acquired pneumonia - what did we learn from the CAPNETZ study?]. Krüger S; Pletz MW; Rohde G Pneumologie; 2011 Feb; 65(2):110-3. PubMed ID: 21117019 [TBL] [Abstract][Full Text] [Related]
12. Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia. Seligman R; Seligman BG; Teixeira PJ J Bras Pneumol; 2011; 37(4):495-503. PubMed ID: 21881740 [TBL] [Abstract][Full Text] [Related]
13. CT-proAVP (copeptin), MR-proANP and Peroxiredoxin 4 after cardiac arrest: release profiles and correlation to outcome. Annborn M; Dankiewicz J; Nielsen N; Rundgren M; Smith JG; Hertel S; Struck J; Friberg H Acta Anaesthesiol Scand; 2014 Apr; 58(4):428-36. PubMed ID: 24617620 [TBL] [Abstract][Full Text] [Related]
14. [High levels of atrial natriuretic peptide and copeptin and mortality risk]. Rey C; García-Cendón C; Martínez-Camblor P; López-Herce J; Concha-Torre A; Medina A; Vivanco-Allende A; Mayordomo-Colunga J An Pediatr (Barc); 2016 Dec; 85(6):284-290. PubMed ID: 26988235 [TBL] [Abstract][Full Text] [Related]
15. Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy. Elmas E; Doesch C; Fluechter S; Freundt M; Weiss C; Lang S; Kälsch T; Haghi D; Papassotiriou J; Kunde J; Schoenberg SO; Borggrefe M; Papavassiliu T Int J Cardiovasc Imaging; 2011 Apr; 27(4):547-56. PubMed ID: 20872251 [TBL] [Abstract][Full Text] [Related]
16. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia. España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199 [TBL] [Abstract][Full Text] [Related]
17. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit. Heining L; Giesa C; Ewig S Lung; 2016 Apr; 194(2):185-91. PubMed ID: 26748496 [TBL] [Abstract][Full Text] [Related]
18. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study. Vazquez M; Jockers K; Christ-Crain M; Zimmerli W; Müller B; Schuetz P Int J Cardiol; 2012 Apr; 156(1):16-23. PubMed ID: 21093937 [TBL] [Abstract][Full Text] [Related]